Injectable Nanobody Wins FDA Approval for Myasthenia Gravis
Summary
(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR...
Description from Medpagetoday.
Who is covering this
-
Injectable Nanobody Wins FDA Approval for Myasthenia Gravis
(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR...
Related stories
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
29 sourcesvia BBC NewsTruth score 9111
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
7 sourcesvia The HinduTruth score 731
Blood pressure medication recalled nationwide
4 sourcesvia USA TODAYTruth score 671
Patanjali ghee among Rs 9 crore food stock seized in Maharashtra FDA crackdown
3 sourcesvia India TodayTruth score 54
Senate committee sets key vote for Trump FDA nominee
5 sourcesvia The HillTruth score 71
Urgent recall of coffee and vanilla ice cream sold at Lidl upgraded to highest risk level over contamination with listeria
3 sourcesvia Daily MailTruth score 53
Comments
Comments need JavaScript.